Skip to main content
. 2023 Feb 22;13(2):e065233. doi: 10.1136/bmjopen-2022-065233

Table 4.

Patient attitudes towards AMR mitigation, stratified by level of information

The patient was provided with additional information on the health and economic consequences of AMR (N, %) Alpha*
No (group A) Yes (group B) Total
Antibiotic prescription should be:
Less restrictive 63 35 98
15.75 8.75 12.25
Unchanged 170 81 251
42.50 20.25 31.37
More restrictive 167 284 451 P<0.01
41.75 71.00 56.38
Total 400 400 800
100.00 100.00 100.00
Willingness to pay more for health treatment that reduced the risk of AMR
Yes 198 322 280
49.50 80.50 35.00
No 202 78 520 P<0.01
50.50 19.50 65.00
Total 400 400 800
100.00 100.00 100.00

Note. Group A—participants not exposed to the intervention (n=400); group B—participants exposed to the intervention (n=400).

*Indicate alpha for statistically significant difference between groups.

AMR, antimicrobial resistance.